Chronic Inflammation (Inflammaging): Difference between revisions

no edit summary
(Created page with "'''Chronic inflammation''', often referred to as '''inflammaging''', is recognized as a significant hallmark of aging. It is characterized by a low-grade, chronic, systemic in...")
 
No edit summary
Line 3: Line 3:
===The Basis of Inflammaging===
===The Basis of Inflammaging===
Inflammaging is driven by several factors, including:
Inflammaging is driven by several factors, including:
*'''Cellular Senescence''': Senescent cells accumulate with age and secrete inflammatory cytokines, chemokines, and proteases, known collectively as the senescence-associated secretory phenotype (SASP). This contributes significantly to the chronic inflammatory state.
*'''[[Cellular Senescence]]''': Senescent cells accumulate with age and secrete inflammatory cytokines, chemokines, and proteases, known collectively as the senescence-associated secretory phenotype (SASP). This contributes significantly to the chronic inflammatory state.
*'''Immune System Dysregulation''': Aging is associated with changes in the immune system, a phenomenon known as immunosenescence, which can lead to an imbalanced immune response and prolonged inflammatory activity.
*'''Immune System Dysregulation''': Aging is associated with changes in the immune system, a phenomenon known as immunosenescence, which can lead to an imbalanced immune response and prolonged inflammatory activity.
*'''Genetic Factors''': Certain genetic predispositions can influence the extent and impact of inflammaging.
*'''Genetic Factors''': Certain genetic predispositions can influence the extent and impact of inflammaging.
Line 11: Line 11:
*'''Cardiovascular Diseases''': Chronic inflammation contributes to the development of atherosclerosis, hypertension, and other cardiovascular conditions.
*'''Cardiovascular Diseases''': Chronic inflammation contributes to the development of atherosclerosis, hypertension, and other cardiovascular conditions.
*'''Metabolic Disorders''': Inflammation is a critical factor in the pathogenesis of insulin resistance, type 2 diabetes, and metabolic syndrome.
*'''Metabolic Disorders''': Inflammation is a critical factor in the pathogenesis of insulin resistance, type 2 diabetes, and metabolic syndrome.
*'''Neurodegenerative Diseases''': Inflammatory processes are involved in the progression of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
*'''[[Neurodegenerative Disorders]]''': Inflammatory processes are involved in the progression of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
*'''Cancer''': Chronic inflammation can lead to DNA damage, promote tumor growth, and suppress immune surveillance.
*'''Cancer''': Chronic inflammation can lead to DNA damage, promote tumor growth, and suppress immune surveillance.
*'''Musculoskeletal Disorders''': Conditions like osteoarthritis and sarcopenia are associated with increased inflammatory activity.
*'''Musculoskeletal Disorders''': Conditions like osteoarthritis and sarcopenia are associated with increased inflammatory activity.
Line 18: Line 18:
*'''Nuclear Factor-kappa B (NF-κB) Pathway''': NF-κB is a key regulator of inflammatory responses. Its persistent activation is a common feature of chronic inflammation and aging.
*'''Nuclear Factor-kappa B (NF-κB) Pathway''': NF-κB is a key regulator of inflammatory responses. Its persistent activation is a common feature of chronic inflammation and aging.
*'''Inflammasomes''': Inflammasomes are protein complexes that promote the production of pro-inflammatory cytokines such as IL-1β and IL-18, contributing to the chronic inflammatory milieu.
*'''Inflammasomes''': Inflammasomes are protein complexes that promote the production of pro-inflammatory cytokines such as IL-1β and IL-18, contributing to the chronic inflammatory milieu.
*'''Dysbiosis''': Alterations in the gut microbiome can lead to increased intestinal permeability and a chronic systemic inflammatory state.
*'''[[Dysbiosis]]''': Alterations in the gut microbiome can lead to increased intestinal permeability and a chronic systemic inflammatory state.
*'''Mitochondrial Dysfunction''': Dysfunctional mitochondria can release reactive oxygen species and other signals that promote inflammatory responses.
*'''[[Mitochondrial Dysfunction]]''': Dysfunctional mitochondria can release reactive oxygen species and other signals that promote inflammatory responses.
===Therapeutic Strategies===
===Therapeutic Strategies===
Several strategies are being investigated to mitigate inflammaging and its impact on age-related diseases:
Several strategies are being investigated to mitigate inflammaging and its impact on age-related diseases: